𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic Significance of Periodic Acid-Schiff-Positive Patterns in Primary Breast Cancer and its Lymph Node Metastases

✍ Scribed by Jeroen T. Buijs; Anne-Marie Cleton; Vincent T.H.B.M. Smit; Clemens W.G.M. Löwik; Socrates E. Papapoulos; Gabri van der Pluijm

Book ID
111575010
Publisher
Springer US
Year
2004
Tongue
English
Weight
816 KB
Volume
84
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of internal mammary lymph node meta
Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients
✍ Dr. Masakuni Noguchi; Nagayoshi Ohta; Michael Thomas; Hirohisa Kitagawa; Itsuo M 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

The risk of an internal mammary lymph node (IMN) metastasis and its prognostic value for patients with invasive breast cancer were assessed by evaluating 142 patients who had either a mastectomy with lymph node dissection or a biopsy of the IMN. By univariate analysis, overall survival significantly

Number of lymph node metastases and its
Number of lymph node metastases and its prognostic significance in early gastric cancer: A multicenter italian study
✍ Franco Roviello; Simone Rossi; Daniele Marrelli; Corrado Pedrazzani; Giovanni Co 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract ## Background and Objectives This study was aimed at evaluating the prognostic significance of the number of metastatic nodes in early gastric cancer (EGC). ## Methods In this multicenter retrospective study 652 cases of resected EGC were analyzed. We searched for lymph node metastas

The prognostic significance of the perce
The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes
✍ Pauline T. Truong; Eric Berthelet; Junella Lee; Hosam A. Kader; Ivo A. Olivotto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Abstract ## BACKGROUND Adjuvant therapy for women with T1–T2 breast carcinoma and 1–3 positive lymph nodes is controversial due to discrepancies in reported baseline locoregional recurrence (LRR) risks. This inconsistency has been attributed to variations in lymph node staging techniques, which